|
The demonstration was part of a program called WellPlay developed by Aviv and Achi Kushnir, B.Sc., brothers from Israel who were pitching WellPlay in the Psychiatry Innovation Zone, APA’s “Shark Tank”–style competition. Hosted by APA’s Committee on Innovation, the program included four competitors who pitched their products to a panel of judges: Neha Chaudhary, M.D., a child and adolescent psychiatrist at Massachusetts General Hospital and chief medical officer of Headway; Rebecca Mitchell, M.D., co-founder and managing partner at Sprout Capital; and Sahib Khalsa, M.D., Ph.D., director of anxiety disorders research at the University of California, Los Angeles, Semel Institute for Neuroscience and Human Behavior.
The winner of the Most Promising Idea Award was MoodFind, an artificial intelligence (AI) program that screens for depression, stress, and anxiety using an individual’s micro expressions—extremely brief, involuntary facial movements.
The Audience Choice Award went to Aviv and Achi Kushnir’s WellPlay, which provides mental health support to patients using AI and psychodrama—which combines roleplaying and psychotherapy.
|